ASCO: Direct Oral Anticoagulant Therapy Feasible for Cancer Patients

TUESDAY, June 6, 2023 -- Direct oral anticoagulant (DOAC) treatment is noninferior to low-molecular-weight heparin (LMWH) for preventing recurrent venous thromboembolism (VTE) in cancer patients, according to a study published online June 2 in the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news